Chronic opioid use during pregnancy: Maternal and fetal implications

Todd J. Stanhope, Lisa A. Gill, Carl Rose

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Current trends in the United States suggest that chronic narcotic use has increased in reproductive aged women over the past 10years. Regular exposure to such substances during pregnancy has maternal and fetal implications. Appropriate prenatal care is critical to optimizing outcomes. Management options for narcotic dependence should be patient-specific and may include discontinuation of narcotics with careful observation, limitation of prescription dispensing, or substitution therapy with methadone or buprenorphine. A multidisciplinary, collaborative approach is highly recommended. This review discusses usage of narcotic medications, associated maternal and fetal risks, and management strategies for the antepartum, intrapartum, and postpartum periods.

Original languageEnglish (US)
Pages (from-to)337-350
Number of pages14
JournalClinics in Perinatology
Issue number3
StatePublished - Sep 2013

Bibliographical note

Copyright 2013 Elsevier B.V., All rights reserved.


  • Buprenorphine
  • Methadone
  • Narcotic
  • Opioid
  • Pregnancy


Dive into the research topics of 'Chronic opioid use during pregnancy: Maternal and fetal implications'. Together they form a unique fingerprint.

Cite this